The effects of vinpocetine (VP), a proposed modulator of production of arachidonic acid metabolites, on disease development and immune functions in rats with adjuvant-induced arthritis (AA) were investigated. Daily i.p. administration of VP (25 mg/kg/for 14 days) to rats with adjuvant-induced arthritis significantly reduced both edema and bone erosion in the hindpaws. After the administration of vinpocetine a decrease of serum hyaluronic acid levels, active lymphocyte number and increase of serum albumin levels were found. Decrease in urine biopterin levels were normalised after treatment with VP.
In conclusion, vinpocetine was shown to have antiinflammatory and antiarthritic effects in rats.
OtomoE.AtarshiJ.ArakiG.ItoE.OmaeT.KuzuyaS.NukadaT.EbiO., 1985. Comparison of vinpocetine with ifenprodil tartrate and dihydroergotexine mesylate treatment, and result of long-term treatment with vinpocetine. Current. Ther. Res., 37: 811.
4.
MachováJ.BauerV.BilčíkováĽ., 1989. Trachealis responses induced by vincamine and vinpocetine, inhibition by indomethacin and Ca2+ dependence. Eur. J. Pharmacol.162:387.
5.
MachováJ.BauerV.BaričičováM.BilčíkováĽ.PerečkováJ., 1990. The role of prostaglandins and calcium in the action of the alkaloid vincamine and its derivative vinpocetine on smooth muscles. Medicines of plant origin in modern therapy, ed. HubíkJ.NovotnýL., Videopress Prague, Prague, Tsumura and Co.Tokyo, Japan, p. 131.
6.
ZurierR.B.1990. Role of prostaglandins E in inflammation and immune responses. Adv. in Prostagl., Thromb., and Leukotr. Res.21:947.
7.
PollockS.H.MatthewsH.W.D'SouzaM.J., 1989. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats. Drug. Metanol. Dispos., 17: 595.
8.
GrimováJ.1971. Significance of X-ray evaluation of bone changes in adjuvant disease in rats. Physiol. Bohemosl., 20: 583.
9.
SmetanaK.LejnarJ.PotmešilM., 1963. A further contribution to the demonstration of RNA and blood cells in smear preparations. Folia Haematol. 91:38.
10.
MikanV.JohnO.MikanA., 1980. Comparison of photometric assessment of albumin and total serum proteins with electrophoresis on the agarose gel. Biochem. Clin. Bohemoslov., 9: 167.
11.
TengbladA.1980. Quantitative analysis of hyaluronate in nanogram amounts. Biochem. J.185:101.
12.
HausenA.FuchsD.KönigK.WachterH., 1982. Determination of neopterin in human urine by reversed phase high-performance liquid chromatography. J. Chromatogr.227:61.
13.
BillinghamM.E.J.1983. Models of arthritis and the search for antirheumatic drugs. Pharmac. Ther.21:389.
14.
AspinallR.L.CammarataP.S., 1969. Effect of prostaglandin E2 on adjuvant arthritis. Nature224:1320.
15.
RovenskýJ.GrimováJ.FuskaJ.LašťovičkaJ.PekárekJ.PokornáJ., 1990. Immunoregulatory effects of Vermiculine in model of adjuvant arthritis. J. Immunopathol. Pharmacol.3:35.
16.
KorčákováL.PekárekJ.RovenskýJ.TrnavskýK.LukáčJ., 1976. Lymphocyte nuclear activation as a marker of autoimmune disorders. Immunol. 31:803.
17.
HaslerF.BluesteinH.ZvaiflerN.EpsteinL., 1983. Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocyte. J. Exp. Med.157:173.
18.
ThompsonP.A.JelinekD.F.LipskyP.E., 1984. Regulation of human B cell proliferation by prostaglandin E2. J. Immunol.133:2446.
19.
GoodwinJ.S.1991. Are prostaglandins proinflammatory, antiinflammatory, both or neither?J. Rheumatol.18:26.
20.
PekárekJ.VepŕekováA.DoutlíkS., 1972. Activation of peripheral lymphocytes in the course of experimental allergic encephalomyelitis in the guinea pig. Z. Immun. Forsch.143:139.
21.
KorčákováL.1973. Blood lymphocyte nuclei activation and skin allograft rejection in mice. Folia Biol. (Praha)19: 25.
22.
LikovskýZ.GrimováJ.DlabačA.HondlíkJ., 1973. Morphological changes in nucleoli of lymphocytes and their influencing by trimethazone, phenylbutazone, indomethacin and 6-mercaptopurine in albino rats with adjuvant-induced disease. Naunyn-Schmiedeberg's Arch. Pharmacol.276:181.
23.
BillinghamM.E.J.GordonA.H., 1976. The role of the acute phase reaction in inflammation. Agents Actions6:195.
Engstrom-LaurentA.HallgrenR., 1985. Circulating hyaluronate in rheumatoid arthritis. The relationship to inflammatory activity and the effect of corticosteroid therapy. Ann. Rheum. Vis.44:83.
26.
AuzébyA.BogdanA.KrosiZ.TuitionY., 1988. Time dependence of urinary neopterin, a marker of cellular immune activity. Clin. Chem.34:1866.
27.
ReibneggerG.EggD.FuchsD.GunterR.HausenA.WernerE.R.WachterH., 1986. Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Arthritis Rheum. 29:1063.
28.
DenmanA.M.1982. Immunosuppression and the rheumatic diseases. Ann. Rheum. Dis. (suppl. 1) 41: 3.
29.
LipskyP.E.1984. Remittive therapy in rheumatoid arthritis: Clinical uses in mechanisms of action. Agents Actions (suppl.)14: 181.
